Literature DB >> 14982515

Association between nasal and bronchial symptoms in subjects with persistent allergic rhinitis.

S R Downie1, M Andersson, J Rimmer, J D Leuppi, W Xuan, A Akerlund, J K Peat, C M Salome.   

Abstract

BACKGROUND: The association between nasal and bronchial symptoms, and the course of bronchial responsiveness and airway inflammation in house dust mite sensitive persistent rhinitis over a prolonged time period has not been thoroughly explored.
OBJECTIVE: To determine if nasal symptoms were associated with bronchial symptoms in persistent rhinitic subjects, and to assess their bronchial responsiveness and airway inflammation in comparison to nonrhinitic, nonatopic controls. The additional impact of pollen sensitivity on the lower airways in rhinitic subjects was also addressed.
METHODS: Rhinitics and controls answered telephone symptom questionnaires once every 2 weeks for 1 year. Every 3 months, exhaled nitric oxide (eNO) and bronchial responsiveness to histamine were measured.
RESULTS: Thirty-seven rhinitics and 19 controls completed the study. High nasal symptom scores in rhinitic subjects were associated with bronchial symptoms (OR = 1.7, 95% CI 1.2-2.5). Bronchial hyper-responsiveness was present in 32.4% of rhinitic subjects on at least one clinical visit during the year. Pollen allergy caused seasonal variation in eNO (P = 0.03).
CONCLUSION: In persistent rhinitic subjects, high nasal symptom scores were associated with bronchial symptoms, and many subjects experienced bronchial hyper-responsiveness during the year. Persistent rhinitic subjects were more at risk than healthy adults of bronchial symptoms and airway inflammation, which are likely risk factors for asthma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14982515     DOI: 10.1111/j.1398-9995.2003.00419.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  11 in total

Review 1.  Potential roles in rhinitis for protease and other enzymatic activities of allergens.

Authors:  Nita Sehgal; Adnan Custovic; Ashley Woodcock
Journal:  Curr Allergy Asthma Rep       Date:  2005-05       Impact factor: 4.806

Review 2.  Catgut implantation at acupoints for allergic rhinitis: a systematic review.

Authors:  Xin-rong Li; Qin-xiu Zhang; Min Liu; Qing Chen; Yang Liu; Fu-bing Zhang; Jing Deng; Zhen-dong Zhong
Journal:  Chin J Integr Med       Date:  2014-03-04       Impact factor: 1.978

3.  Association of nasal inflammation and lower airway responsiveness in schoolchildren based on an epidemiological survey.

Authors:  Jun-Ho Myung; Hyun-Jeong Seo; Soo-Jeong Park; Bo-Young Kim; Il-Sang Shin; Jun-Hak Jang; Yun-Kyung Kim; An-Soo Jang
Journal:  Korean J Intern Med       Date:  2015-02-27       Impact factor: 2.884

4.  The pathophysiology, diagnosis and treatment of allergic rhinitis.

Authors:  Yang-Gi Min
Journal:  Allergy Asthma Immunol Res       Date:  2010-03-24       Impact factor: 5.764

Review 5.  The atopic march: what's the evidence?

Authors:  Jennifer Ker; Tina V Hartert
Journal:  Ann Allergy Asthma Immunol       Date:  2009-10       Impact factor: 6.347

Review 6.  Allergy and the nose.

Authors:  G Ciprandi; G Passalacqua
Journal:  Clin Exp Immunol       Date:  2008-09       Impact factor: 4.330

Review 7.  Allergic rhinitis: evidence for impact on asthma.

Authors:  Mike Thomas
Journal:  BMC Pulm Med       Date:  2006-11-30       Impact factor: 3.317

8.  Allergic Rhinitis: A neglected disease - A community based assessment among adults in Delhi.

Authors:  B Sinha; R Singla; R Chowdhury
Journal:  J Postgrad Med       Date:  2015 Jul-Sep       Impact factor: 1.476

9.  Involvement of T-Helper 9 Activation in a Mouse Model of Allergic Rhinitis.

Authors:  Xunshuo Jiang; Xiaona Zhang; Jianguo Liu; Jiali Liu; Xinhua Zhu; Chunping Yang
Journal:  Med Sci Monit       Date:  2018-07-08

10.  Exhaled and Nasal Nitric Oxide - Impact for Allergic Rhinitis.

Authors:  M Antosova; A Bencova; D Mokra; J Plevkova; L Pepucha; T Buday
Journal:  Physiol Res       Date:  2020-03-27       Impact factor: 1.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.